Differentiated and exponentially growing HL60 cells exhibit different sensitivity to some genotoxic agents in the comet assay by Montag, Gracia et al.
Contents lists available at ScienceDirect
Mutat Res Gen Tox En
journal homepage: www.elsevier.com/locate/gentox
Differentiated and exponentially growing HL60 cells exhibit different
sensitivity to some genotoxic agents in the comet assay
Gracia Montaga, Ezgi Eyluel Bankoglua, Annika Boltea, Henning Hintzschea,b, Ninoslav Djelicc,
Helga Stoppera,⁎
a Institute of Pharmacology and Toxicology, University of Wuerzburg, Versbacherstr. 9, 97078, Wuerzburg, Germany
b Bavarian Health and Food Safety Authority, Eggenreuther Weg 43, 91058, Erlangen, Germany
cDepartment of Biology, Faculty of Veterinary Medicine, University of Belgrade, Oslobodjenja Blvd. 18, 11000, Belgrade, Serbia
A R T I C L E I N F O
Keywords:
Comet assay
HL60 cell
Cell differentiation
Genotoxicity
A B S T R A C T
The aim of this study was to investigate the effect of the cell differentiation status on the sensitivity to genotoxic
insults. For this, we utilized the comet assay to test the DNA damage after treatment with 5 different substances
with different mechanism of action in human promyelocytic HL60 cells with or without cell differentiation.
A 4-hour MMS treatment induced a significant and concentration-dependent increase in DNA damage for both
differentiated and undifferentiated cells, but the difference in sensitivity was only significant at the highest
concentration. A 4-hour doxorubicin treatment did not induce DNA damage in differentiated HL60 cells, while it
did in undifferentiated cells with its highest tested concentration. A one-hour etoposide treatment caused sig-
nificant increase in DNA damage concentration dependently in both cell variants. This DNA damage was sig-
nificantly higher in undifferentiated HL60 cells with several tested concentrations of etoposide. The treatment
with the oxidizing substances hydrogen peroxide and potassium bromate yielded significant DNA damage in-
duction in both undifferentiated and differentiated cells with no difference according to the differentiation
status.
Doxorubicin and etoposide are known to inhibit topoisomerase II. The activity of this enzyme has been shown
to be higher in undifferentiated actively proliferating cells than in differentiated cells. This may be of relevance
when exposures to topoisomerase-inhibiting compounds or the genotoxicity of compounds with unknown me-
chanism of action are assessed in routine testing.
1. Introduction
The promyelocytic cell line HL60 was established from a female
patient with acute myeloid leukaemia [1]. The cells display a myelo-
blastic/promyelocytic morphology and carry typical surface antigens
and some other characteristics of immature myeloid cells [2]. With this,
they represent a maturation state that is between pluripotent hemato-
poietic and myeloid stem cell. Since hematopoietic cancers induced by
chemical agents originate in less differentiated cell stages during the
maturation of hematopoietic stem cells, and because about 25 of the
100 known human carcinogens induce leukaemia or lymphomas [3],
HL60 cells may be considered a suitable model for the investigation of
mutagenic chemicals.
HL60 cells can differentiate into a granulocyte-like or a monocyte-
like form. This occurs spontaneously during cell culture and about 10%
of cells are differentiated during normal culture [2]. Upon treatment
with certain chemicals, differentiation of the majority of the cultured
cells (up to 90%) can be induced [2]. For example, with DMSO or re-
tinoic acid differentiation is into granulocyte-like cells and with
phorbol esters or sodium butyrate cells differentiate into a monocyte-
like cell type [2]. This enables the investigation of the relevance of the
differentiation state for the sensitivity to genotoxic agents. However,
only tests that do not require cell proliferation or mitosis can be ap-
plied, because differentiated cells do not divide any more. The comet
assay fulfils this condition as it is suitable for any cell type from which a
single cell suspension can be prepared.
While the majority of in vitro genotoxicity testing is performed with
actively dividing cultured cells, there are some circumstances in which
genotoxicity is routinely assessed in differentiated cells. In rodents, the
comet assay is used for the assessment of organ-specific genotoxic ef-
fects in the context of mutagenicity testing during the registration
process of substances [4]. Most of these organ-derived primary cells are
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not in a state of exponential growth. In human biomonitoring, per-
ipheral mononuclear cells are used, which is a population consisting of
cells in different differentiation stages. The comet assay has also been
employed in neurotoxicity testing for the measurement of DNA damage
in differentiated brain cells [5,6].
For HL60, certain differences like level of cellular glutathione and
topoisomerase II between the undifferentiated and the differentiated
state have been described (e.g. [2,7–9],) but so far there is no published
genotoxicity study comparing both states for their sensitivity.
We tested 5 compounds with various mechanisms of action for
which the comet assay shows good sensitivity. Hydrogen peroxide
(H2O2) and potassium bromate (KBrO3) are known to induce oxidative
stress, methyl methane sulfonate (MMS) is an alkylating agent, doxor-
ubicin is an intercalating substance and etoposide a topoisomerase II
inhibitor. Differentiated and undifferentiated cells were treated in
parallel and were subjected to electrophoresis on two gels of the same
slide, minimizing intra- and inter-experimental variation.
2. Materials and methods
2.1. Materials
Unless stated otherwise, chemicals were purchased from Sigma
Aldrich Germany (Munich, Germany). Cell culture media and reagents
were purchased from PAA Laboratories (Pasching, Austria) and Life
Technologies (Darmstadt, Germany). Fetal bovine serum (FBS) was
from Biochrom (Berlin, Germany). Normal melting point agarose and
super frost slides were from Carl Roth (Karlsruhe, Germany). The
GelGreen nucleic acid stain was purchased from Biotium (Hayward, CA,
USA). Dimethyl sulfoxide (DMSO) was obtained from Carl-Roth
(Karlsruhe, Germany). HL60 cells were obtained from R. Schinzel,
Vasopharm (Wuerzburg, Germany).
FPG protein (Formamidopyrimidine-DNA glycosylase of Escherichia
coli) was gained from E. coli strain JM105, which carries the plasmid
pFPG230. This E. coli strain was kindly supplied by Prof. Dr. Bernd Epe
(University of Mainz).
2.2. Methods
2.2.1. Cell culture
HL60 cells were cultured in RPMI-1640 medium supplemented with
10% (v/v) fetal calf serum, 1% (w/v) L-glutamine and 0.4% (w/v) an-
tibiotic (penicillin/streptomycin) in an incubator with 5% CO2 at 37 °C.
The differentiation of HL60 cells was achieved with 1.25% DMSO
treatment over 72 h, conditions which had been found optimal in pre-
liminary experiments. The culture medium supplied with 1.25% DMSO
was renewed every 24 h. After 48 h of differentiation, the cell number
of differentiated HL60 was scored in order to seed undifferentiated
HL60 cells at an adjusted density of half of that of the differentiated
cells. This provided equal cell densities for both cell types at the time of
substance treatment. After 72 h of differentiation, differentiated and
undifferentiated (seeded one day prior to the treatment) HL60 cells
were treated with the test substances (4 h with methyl methane sulfo-
nate (MMS; 25, 50, 75, 100, 150 and 250 μM) and doxorubicin (50,
100, 150, 200, 250 and 500 μM); one hour with etoposide (0.1, 0.5, 1,
5, 10 and 25 μM); 30min with hydrogen peroxide (H2O2; 25, 50, 75,
100, 125, 150 and 175 μM) and 3 h with potassium bromate (KBrO3;
50, 100 and 150 μM)).
2.2.2. Morphological analysis of differentiation status
The differentiation status of the HL60 cells was determined micro-
scopically according to nuclear morphology (granulocyte-like shape,
see Fig. 1). In previous experiments, it had been confirmed that this
appearance correlates with an increase of the differentiation-specific
surface marker CD11b [10]. We had also confirmed that the expression
of the insulin receptor is markedly decreased in this state as described
in the literature [11] (and own unpublished observation). At the end of
the 72 h, the cells (differentiated and undifferentiated) were placed on a
glass slide by cytospin centrifugation (1000 rpm for 5min, 30,000 cells/
slide). The slides were fixed in cold methanol (−20 °C) for at least 2 h
and stained with GelGreen nucleic stain (1:100 diluted in bidistilled
water). Coverslips were mounted with Dabco and 400-cells per sample
(2×200 cells per group) were analysed with an Eclipse 55i microscope
(Nikon GmbH, Düsseldorf, Germany) at 400-fold magnification by
using a FITC filter to ensure a differentiation of more than 80% of cells.
2.2.3. Comet assay
After treatment of the cells with test substances (see 2.2.1), cells
were harvested and 20 μl of cell suspension (contains 3500 cells/μl) was
mixed with 180 μl of 0.5% low melting point agarose at 37 °C. Thirty-
eight μl of cell-agarose mixture was placed on a fully frosted slide that
was coated with 1.5% of normal melting point agarose. Two agarose
gels were placed on each slide. The cell suspensions were covered with
two cover glasses and the slides were kept at 4 °C for 30 s to solidify the
mixture. After gentle removal of the cover glasses, slides were kept in a
lysis solution (1% Triton X-100, 10% dimethyl sulfoxide, and 89% lysis
buffer containing 10mM Tris, pH 10; 2.5M NaCl; and 100mM
Na2EDTA) for 1 h in the dark at 4 °C. After the lysis step, to allow DNA
unwinding, the slides were placed in an electrophoresis chamber that
was filled with fresh electrophoresis buffer (300mM NaOH and 1mM
Na2EDTA, pH 13) for 30min at 4 °C in dark (20min for FPG comet
assay). Then the electrophoresis was performed for 30min (20min for
FPG comet assay) at 25 V (1.1 V/ cm). To neutralize the slides, they
were immersed in 0.4M Tris buffer (pH 7.5) for 5min and then to
dehydrate in methanol for 5min at −20 °C. For FPG comet assay, an
enzyme treatment step was performed directly after the lysis step and
before the alkaline unwinding. For each treatment group two agarose
gels were treated with FPG enzyme (8 μg/ml protein, 100 μl per gel)
and two agarose gel replicates from the same sample were treated with
the enzyme buffer (40mM Hepes, 100mM KCl, 0.5mM Na2EDTA and
0.2 mg/ml BSA, pH 8.0). The treatment was at 37 °C for 30min. After
the enzyme treatment, the slides were washed with enzyme buffer and
Fig. 1. Differentiation after a 72-h DMSO treatment assessed by morphological
alteration of nuclear shape of HL60cells. A HL60 cells without DMSO treatment
(undifferentiated) and B HL60 cells after 72 h of 1.25% DMSO treatment (dif-
ferentiated). As historical control values across all experiments in this study,
percentages of undifferentiated cells and of granulocytic cell differentiation by
DMSO treatment are presented as Mean ± SD of 40 independent experiments.
* p≤ 0.05 vs. 0% DMSO.
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the rest of the steps after the lysis were performed as described above
(alkaline unwinding for 20min and electrophoresis for 20min). After
the methanol fixation, the slides were left to dry under a fume hood and
stained with 20 μl of Gel red/ Dabco solution. Evaluations of the slides
were done with a fluorescence microscope (Labophot 2; Nikon) at 200-
fold magnification and image analysis software (Komet 5, BFI Optilas,
Germany). One hundred randomly selected cells (50 per replicate
agarose gels) for each treatment were analysed. The percentage of DNA
in the tail was used to quantify DNA damage. The FPG comet assay
results are presented as Net DNA in tail, which was calculated as the
percent of DNA in tail with FPG after subtraction of the values without
FPG according to following formula.=Net DNA in tail DNA in tail DNA in tail(%) [ (%) ] [ (%) ]FPG w oFPG/
2.2.4. Viability test
At the time of the cell harvest for comet assay, a cell viability test
was performed with the same cell pellet. For this, 35 μl of cell suspen-
sion were mixed with 15 μl of staining solution (2 μl Gel Red stock so-
lution and 12 μl fluorescein diacetate (FDA; 5mg/ml in acetone) in 2ml
PBS) and 45 μl of this mixture was applied on the slide and covered
with a cover slip. FDA is activated to exhibit green fluorescence by
cytosolic esterases in intact cells, while Gel Red can only enter cells
with compromised membrane integrity. In total 200 cells (red and
green stained) were scored with an Eclipse 55i microscope (Nikon
GmbH, Düsseldorf, Germany) at 200-fold magnification by using FITC
filter. The proportion of vital cells to dead cells was determined.
2.2.5. Statistics
Statistical analysis was performed by using SPSS 22 software. The
data are presented as Mean ± SD. The Shapiro-Wilk test was per-
formed to test the normality of the data and the Mann-Whitney-U test
was used to compare the differences between two treatment groups.
The results with a p value ≤0.05 were considered as significant.
3. Results
3.1. Differentiation status of HL60 cells after 72-h-DMSO treatment
The differentiation status of the HL60 cells following to 72 h DMSO
treatment was assessed microscopically. Clear morphological altera-
tions of the shape of the cell nucleus were observed in the DMSO
treated group (Fig. 1). With a 72-h-DMSO treatment, 89.40 ± 5.30
(Mean ± SD) percent of the HL60 population were differentiated
(n=40; average of all controls within the time frame of the experi-
mental work for this publication). In regular HL60 culture (without
DMSO treatment), 15.01 ± 4.13 (Mean ± SD) percent of the HL60
population was spontaneously differentiated (n= 40).
3.2. DNA damage induction by methyl methanesulfonate (MMS) treatment
Comet assay analysis revealed that a 4-hour MMS treatment yielded
a concentration-dependent increase in DNA damage which was sig-
nificant with 100 μM or more in undifferentiated and differentiated
HL60 cells. Differentiated HL60 cells showed slightly lower DNA da-
mage compared to the undifferentiated cells. However, this difference
between undifferentiated and differentiated cells only became sig-
nificant with the highest tested concentration of MMS (250μM) (Fig. 2)
and in another set of experiments with 150 μM MMS, when it was used
as positive control in the doxorubicin treatment (Fig. 3).
3.3. DNA damage induction by doxorubicin treatment
A 4-hour doxorubicin treatment led to an increase in DNA damage
in undifferentiated HL60 cells in the comet assay, which was significant
with 500 nM. In contrast, differentiated HL60 cells did not show any
increase in DNA damage with doxorubicin treatment. In this experi-
ment, 150 μM of MMS treatment was added as positive control, which
caused a significant increase in DNA damage in both cell types. Thus, a
significant difference in DNA damage levels induced by doxorubicin
was observed between undifferentiated and differentiated HL60 cells
with the undifferentiated cells reacting with higher sensitivity (Fig. 3).
3.4. DNA damage induction by etoposide treatment
An hour etoposide treatment yielded a concentration dependent
increase in DNA damage for undifferentiated and differentiated HL60
cells in the comet assay. The lowest concentration, which caused a
significant increase of DNA damage was 0.5 μM for undifferentiated
HL60 cells and 1 μM for differentiated HL60 cells. The difference be-
tween undifferentiated and differentiated cells in comet assay was
significant with 0.5 μM etoposide and higher concentrations. The un-
differentiated HL60 cells reacted to the etoposide treatment with higher
sensitivity than the differentiated cells (Fig. 4).
3.5. DNA damage induction by hydrogen peroxide treatment
A 30min hydrogen peroxide (H2O2) treatment led to a significant
Fig. 2. DNA damage level in undifferentiated and differentiated HL60 cells
after 4-hour MMS treatment. Undifferentiated HL60 cells are shown in white
and differentiated HL60 cells are shown in black color. Data are presented as
Mean ± SD of 3 independent experiments. *p≤0.05 vs. 0μM MMS treated
undifferentiated HL60 cells, Δp≤ 0.05 vs. 0μM MMS treated differentiated
HL60 cells and #p≤0.05 vs. undifferentiated HL60 cells.
Fig. 3. DNA damage level in undifferentiated and differentiated HL60 cells
after a 4-hour doxorubicin treatment. Undifferentiated HL60 cells are shown in
white and differentiated HL60 cells are shown in black color. PC: positive
control, 150 μM MMS for 4-hour. Data are presented as Mean ± SD of 3 in-
dependent experiments. *p≤0.05 vs. 0μM doxorubicin treated un-
differentiated HL60 cells, Δp≤ 0.05 vs. 0μM doxorubicin treated differentiated
HL60 cells and #p≤0.05 vs. undifferentiated HL60 cells.
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increase of DNA damage with all used concentrations in both cell types.
An increasing amount of DNA damage was observed with increasing
H2O2 concentrations. The differentiation status of the HL60 cells did
not show any effect on DNA damage after this treatment (Fig. 5). A FPG
comet assay was utilized to determine the differences specifically in
oxidative DNA damage after hydrogen peroxide treatment (25, 50 and
75 μM). A concentration dependent increase was observed after FPG
enzyme treatment in both cell types (undifferentiated and differentiated
HL60). However, there was no difference in induced oxidative DNA
damage between the undifferentiated and differentiated cells (Fig. 6).
3.6. DNA damage induction by potassium bromate treatment
A 3-hour potassium bromate (KBrO3) treatment did not cause DNA
damage induction without FPG treatment (not shown). After the in-
cubation with FPG enzyme, a concentration dependent increase in DNA
damage was observed for both cell types (undifferentiated and differ-
entiated HL60). All chosen concentrations of potassium bromate
yielded a significant increase in DNA damage after the FPG-incubation.
There was no difference in DNA damage levels between un-
differentiated and differentiated cells (Fig. 7).
3.7. Cell viability
The tested substances did not induce cytotoxic effects in un-
differentiated or differentiated HL60 cells after the applied treatment
periods (4 h for MMS and doxorubicin, one hour for etoposide, 30min
for H2O2 and 3 h for KBrO3) and the applied conditions; there was no
significant difference to the respective solvent controls (data not
shown).
4. Discussion
HL60 cells were induced to differentiate into a granulocyte-like cell
type by treatment with DMSO over 72 h. The differentiated state was
compared with exponentially growing undifferentiated HL60 cells
within one experiment in parallel treatments and in two gels on the
same slide during comet assay procedures. The treatment conditions for
the different genotoxic agents were chosen according to prior experi-
ences. A 4-hour treatment duration was performed for MMS and dox-
orubicin, while etoposide treatment duration was one hour. A 30min
Fig. 4. DNA damage level in undifferentiated and differentiated HL60 cells
after an hour etoposide treatment. Undifferentiated HL60 cells are shown in
white and differentiated HL60 cells are shown in black color. Data are pre-
sented as Mean ± SD of 3 independent experiments. *p≤0.05 vs. 0μM eto-
poside treated undifferentiated HL60 cells, Δp≤0.05 vs. 0μM etoposide treated
differentiated HL60 cells and #p≤0.05 vs. undifferentiated HL60 cells.
Fig. 5. DNA damage level in undifferentiated and differentiated HL60 cells
after 30min H2O2 treatment. Undifferentiated HL60 cells are shown in white
and differentiated HL60 cells are shown in black color. Data are presented as
Mean ± SD of 3 independent experiments. *p≤0.05 vs. 0μM H2O2 treated
undifferentiated HL60 cells, Δp≤0.05 vs. 0μM H2O2 treated differentiated
HL60 cells and #p≤0.05 vs. undifferentiated HL60 cells.
Fig. 6. DNA damage level in undifferentiated and differentiated HL60 cells
after 30min H2O2 treatment with FPG enzyme incubation. Undifferentiated
HL60 cells are shown in white color and differentiated HL60 cells are shown in
black color. Data are presented as Mean ± SD of 4 independent experiments.
*p≤ 0.05 vs. 0μM H2O2 treated undifferentiated HL60 cells and Δp≤0.05 vs.
0μM H2O2 treated differentiated HL60 cells.
Fig. 7. DNA damage level in undifferentiated and differentiated HL60 cells
after a 3-hour potassium bromate (KBrO3) treatment with FPG enzyme in-
cubation. Undifferentiated HL60 cells are shown in white color and differ-
entiated HL60 cells are shown in black color. Data are presented as Mean ± SD
of 4 independent experiments. *p≤ 0.05 vs. 0μM KBrO3 treated un-
differentiated HL60 cells and Δp≤0.05 vs. 0μM KBrO3 treated differentiated
HL60 cells.
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treatment was chosen for H2O2 and a 3-hour treatment for KBrO3. None
of the test substances induced cytotoxicity under the applied treatment
conditions.
MMS treatment yielded a slight difference in DNA damage between
undifferentiated and differentiated HL60 cells only at the highest tested
concentration. However, a difference in sensitivity between the cell
types was much more apparent after doxorubicin treatment, for which
the differentiated HL60 cells were insensitive. This is in accordance
with a report by Ganapathi et al. [12], in which a doxorubicin re-
sistance of HL60 cells was detected after differentiation with retinoic
acid. Two main mechanisms of action can be named for doxorubicin:
DNA intercalation leading to topoisomerase II inhibition and reactive
oxygen species formation. To determine which mechanism causes the
difference in sensitivity, we applied the specific topoisomerase II in-
hibitor etoposide next. The undifferentiated HL60 cells showed sig-
nificantly higher DNA damage against etoposide treatment compared to
the differentiated HL60 cells. To test whether the reactive oxygen
species are also a contributing factor to the different sensitivity, we then
applied H2O2 and KBrO3 (with FPG). Both compounds induced very
similar amounts of damage in both cell types. In line with this, in a test
for oxidative stress production, flow cytometry measurement of oxi-
dation of the dye DCF-DA, doxorubicin did not induce an effect in
differentiated or undifferentiated HL60 cells (data not shown). Thus, it
seems that topoisomerase II inhibition may be a mechanism for which
differentiated cells are less sensitive. Actually, different amounts of
topoisomerase II expression after differentiation (myeloid differentia-
tion, granulocytic) had been described in HL60 cells earlier [7]. To-
poisomerase II alpha (topo II α), the isoform which is involved in the
preparation of chromatin for mitosis, decreases during differentiation of
HL-60 cells, while topoisomerase II beta (topo II β) expression remains
largely unchanged. Etoposide can inhibit both isoforms of topoisome-
rase II, but shows more affinity to the II alpha isoform [13–15].
Here, we did not observe different sensitivities for reactive oxygen
species, as shown by H2O2 and KBrO3 treatment. However, Covacci
et al., [8], demonstrated higher ROS levels and higher DNA damage in
undifferentiated HL60 cells compared to the DMSO-differentiated HL60
cells after H2O2 treatment. They explained this by an increased glu-
tathione level after cell differentiation. This difference with our in-
vestigation might be due to the variations in HL60 cells. It is known that
after the initial culture sub-lineages with slightly varying genome have
developed over the last decades [16].
Another potential difference between differentiated and un-
differentiated cell states might be the DNA repair capacity.
Differentiated cells do not replicate any more, and therefore do not
transmit genomic damage to daughter cells. Since only functionality of
expressed proteins has to be ensured after differentiation, the removal
of DNA lesions might be less stringent. Lee and colleagues [17] in-
vestigated the effect of differentiation status on expression and activity
of human 8-oxo-G-DNA glycosylase 1 (hOGG1). They showed increased
expression level of OGG1 both after granulocytic (by DMSO treatment)
and monocytic (by vitamin D3 treatment) cellular differentiation.
However, these findings did not show any correlation with the cleavage
activity of hOGG1 enzyme. Opposite to expression, the cleavage activity
of hOGG1 was reduced after granulocytic differentiation in HL60 cells.
In addition, nucleotide excision repair (NER) of UV-induced lesions has
been found less efficient in TPA-differentiated HL60 cells (monocyte/
macrophage differentiation) [9]. Hsu and colleagues [18] showed a
reduced repair of cisplatin induced crosslinks after differentiation of
HL60 cells (monocyte/macrophage differentiation). None of the sub-
stances tested here relies solely on NER for the induction of DNA da-
mage in the comet assay, but NER might play a role in the MMS-in-
duced damage which may explain the difference observed between
undifferentiated and differentiated cells at the highest tested con-
centration (higher % DNA in tail due to higher incision activity in un-
differentiated cells). Therefore, it would be interesting to investigate
NER activity further for differentiation of HL60 into the granulocyte-
like cell type.
The question whether the observed differences in sensitivity due to
differentiation also occur in other cell types is still open. We used the
human colon cancer cell line Caco2 cells as an alternative cellular
system, in which differentiation is induced by contact inhibition after
21-day continued culture. At this time the cells form a confluent
monolayer and show a typical formation of cell domes. The un-
differentiated Caco2 cells showed significantly higher DNA damage
after one-hour etoposide treatment compared to the differentiated
Caco2 cells [19], which may support the idea that not only HL60 cells,
but many/most or all cells reduce the expression of topo II α during
differentiation. In an earlier study [20], we had observed reduced in-
duction of damage in the comet assay with the topo II inhibitors eto-
poside and amsacrine during the course of in vitro induced differ-
entiation of the mouse embryonal carcinoma cell line F9. These ideas
are also in line with observations by Prosperi et al. [21], that resting
peripheral lymphocytes express very low levels of topo II α and β, but
still 2.5 fold more topo II β than topo II α; upon PHA-stimulation, topo
II α and β levels increased up to 30-fold (α) and 10-fold (β) to before.
When Gajski et al. [22], quantified the response of peripheral lym-
phocytes to etoposide, they found a 10-fold higher sensitivity in the
micronucleus test which requires PHA- stimulation than in the comet
assay, which only yielded a significant response after a 48-hour treat-
ment with 10 μM etoposide in resting lymphocytes. Furthermore, Ker-
sting et al. [23], reported that the different response regarding apop-
tosis of peripheral lymphocytes to doxorubicin between individuals
depended on the activity of topo II β, which varied 16-fold between
individuals. In a comparison between proliferation-stimulated human
hematopoietic stem cells (HSC) and the human lymphoblast im-
mortalized cell line TK6 we observed a lower sensitivity in HSC to
micronucleus induction and apoptosis after treatment with MMS or
doxorubicin [24]. These two cell types may represent different stages of
cell differentiation within the human hematopoietic cell system, but
were both proliferating at the time of assessment in the micronucleus
test. Since stem cells are considered a target for carcinogenesis, a
comparison of resting stem cells with proliferating stem cells would be a
very important future study.
Overall, our findings show that the cell differentiation status can
have an impact on the sensitivity of cell systems against certain geno-
toxic insults. This should be kept in mind in mutagenicity testing of
uncharacterized substances as well as in biomonitoring of human ex-
posures.
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